Analytical Data
-
基因名
GNL2
- Application
-
别名
Autoantigen NGP-1
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q13823
-
表达区间
1-731aa
-
分子量
99.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GNL2, or Guanine nucleotide-binding protein-like 2, is a member of the GTPase family and plays a vital role in various cellular processes, including ribosome biogenesis, cellular proliferation, and stress response. Its involvement in multiple biological pathways makes GNL2 a key player in cellular homeostasis. Recent studies have indicated that GNL2 is overexpressed in several types of cancers, suggesting a potential link to tumorigenesis and making it a promising target for cancer research. The functional characterization of GNL2, particularly through the study of its recombinant protein, is essential to elucidate its specific roles within the cell and its mechanisms of action. By producing and analyzing GNL2 recombinant proteins, researchers aim to gain insights into its biochemical properties, interacting partners, and regulatory mechanisms, which could potentially open avenues for therapeutic interventions in cancer and other diseases associated with GNL2 dysregulation. Given the rising interest in targeting GTPases in cancer treatment, understanding GNL2 through recombinant protein studies could contribute significantly to the field of cancer biology and targeted therapy.
